you are here:

Alembic Pharmaceuticals Ltd.

BSE: 533573 | NSE: APLLTD |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE901L01018 | SECTOR: Pharmaceuticals

BSE Live

Jan 21, 16:00
776.90 -5.00 (-0.64%)
Volume
AVERAGE VOLUME
5-Day
10,824
10-Day
52,844
30-Day
35,792
8,936
  • Prev. Close

    781.90

  • Open Price

    780.35

  • Bid Price (Qty.)

    770.00 (11)

  • Offer Price (Qty.)

    773.30 (46)

NSE Live

Jan 21, 15:49
774.10 -8.50 (-1.09%)
Volume
AVERAGE VOLUME
5-Day
160,115
10-Day
262,467
30-Day
357,345
400,857
  • Prev. Close

    782.60

  • Open Price

    781.00

  • Bid Price (Qty.)

    774.10 (204)

  • Offer Price (Qty.)

    0.00 (0)

Financials

2021 2020 2019 2018 2017
Quarterly Results of Alembic Pharmaceuticals (in Rs. Cr.) Sep '21 Jun '21 Mar '21 Dec '20 Sep '20  
Net Sales/Income from operations 1,189.77 1,269.69 1,157.24 1,235.77 1,400.01  
Other Operating Income -- -- -- -- --  
Total Income From Operations 1,189.77 1,269.69 1,157.24 1,235.77 1,400.01  
EXPENDITURE  
Consumption of Raw Materials 247.05 287.02 270.57 325.55 322.66  
Purchase of Traded Goods 76.60 112.83 71.00 74.61 85.72  
Increase/Decrease in Stocks 28.96 -17.58 -39.73 -91.43 -63.82  
Power & Fuel -- -- -- -- --  
Employees Cost 266.80 261.59 212.01 236.53 250.36  
depreciat 44.53 43.49 41.84 38.21 36.71  
Excise Duty -- -- -- -- --  
Admin. And Selling Expenses -- -- -- -- --  
R & D Expenses -- -- -- -- --  
Provisions And Contingencies -- -- -- -- --  
Exp. Capitalised -- -- -- -- --  
Other Expenses 333.42 348.86 322.40 318.76 348.94  
P/L Before Other Inc. , Int., Excpt. Items & Tax 192.42 233.48 279.15 333.54 419.44  
Other Income 1.71 1.74 4.03 2.71 2.84  
P/L Before Int., Excpt. Items & Tax 194.13 235.22 283.18 336.25 422.28  
Interest 4.41 2.03 2.14 2.21 2.33  
P/L Before Exceptional Items & Tax 189.71 233.19 281.04 334.04 419.95  
Exceptional Items -- -- -- -- --  
P/L Before Tax 189.71 233.19 281.04 334.04 419.95  
Tax 33.36 40.50 49.93 56.69 71.65  
P/L After Tax from Ordinary Activities 156.36 192.69 231.11 277.35 348.30  
Prior Year Adjustments -- -- -- -- --  
Extra Ordinary Items -- -- -- -- --  
Net Profit/(Loss) For the Period 156.36 192.69 231.11 277.35 348.30  
Equity Share Capital 39.31 39.31 39.31 39.31 39.31  
Reserves Excluding Revaluation Reserves -- -- -- -- --  
Equity Dividend Rate (%) -- -- -- -- --  
EPS Before Extra Ordinary  
Basic EPS 7.95 9.80 11.76 14.11 18.02  
Diluted EPS 7.95 9.80 11.76 14.11 18.02  
EPS After Extra Ordinary  
Basic EPS. 7.95 9.80 11.76 14.11 18.02  
Diluted EPS. 7.95 9.80 11.76 14.11 18.02  
Public Share Holding  
No Of Shares (Crores) -- -- -- -- --  
Share Holding (%) -- -- -- -- --  
Promoters and Promoter Group Shareholding  
a) Pledged/Encumbered  
- Number of shares (Crores) -- -- -- -- --  
- Per. of shares (as a % of the total sh. of prom. and promoter group) -- -- -- -- --  
- Per. of shares (as a % of the total Share Cap. of the company) -- -- -- -- --  
b) Non-encumbered  
- Number of shares (Crores). -- -- -- -- --  
- Per. of shares (as a % of the total sh. of prom. and promoter group). -- -- -- -- --  
- Per. of shares (as a % of the total Share Cap. of the company). -- -- -- -- --  
Source : Dion Global Solutions Limited